论文研究 arXiv cs.CV Tue, 04 Aug 2026 正文 ok 324 words

病理学基础模型图谱中的信号来自何处?乳腺癌患者级对照基准测试

英文标题:What Carries the Signal in Pathology Foundation-Model Atlases? A Patient-Level Controlled Benchmark in Breast Cancer

该研究以患者而非队列级基因排序为证据单位,评估病理学基础模型能否从组织形态中预测留出患者的分子程序。研究覆盖 11 个冻结骨干模型、4 个预先指定的基因程序及 285 名具有配对切片和 RNA-seq 数据的 TCGA-BRCA 患者,UNI2 在全部四项任务中表现最佳,免疫程序的 Spearman 相关系数达到 0.556。结果表明,嵌入特征在 ER/腔面型、增殖和免疫程序预测上显著优于组织组成特征,但在 basal 程序上并无明显优势,且可解释的细胞计数特征已能取得接近的表现。研究还发现,相关几何图方法未带来可测量收益,岭回归显著优于图与度量解码器,这为开发者评估病理基础模型的真实信息来源和方法复杂度提供了患者级验证依据。
打开原文相关 1.6 · 机会 0
media2.6 KB media2.1 KB media640 B media612 B media380 B media9.1 KB media32.7 KB media22.8 KB media24.2 KB media34.7 KB

中文

[提交于 2026 年 7 月 31 日]

标题:病理学基础模型图谱中的信号来自何处?乳腺癌患者级对照基准测试

查看 Chimdi Walter Ndubuisi 撰写的论文《病理学基础模型图谱中的信号来自何处?乳腺癌患者级对照基准测试》的 PDF。

查看 PDF HTML(实验性)

摘要:已有研究称,病理学基础模型能够在组织形态中编码分子程序,但相关证据通常是队列范围内的基因排序列表,而非对留出患者的预测。我们以患者为证据单位重建了这类分析,并考察究竟是流水线中的哪个组件承载了信号。
在 11 个冻结骨干模型、4 个预先指定的基因程序,以及 285 名具有配对切片和 RNA-seq 数据的 TCGA-BRCA 患者中(44 个单元;按患者进行 GroupKFold;所有预处理均在折内拟合),对均值池化嵌入使用岭回归,可预测留出患者的程序得分,Spearman rho 为 0.25–0.56;UNI2 在全部四个程序上最强(免疫程序为 0.556)。匹配的置换零假设检验显示,在 10,000 次置换下,每个单元的原始 p 值约为 1e-4;Holm 校正后的 p 值为 0.0044。
该信号真实存在,但并非一致地来自形态学信息。与在相同患者和相同交叉验证折上运行的竞争模型相比,嵌入特征在 ER/腔面型、增殖和免疫程序上优于组织组成特征(分别为 +0.280、+0.284、+0.479;p <= 0.003),但在 basal 程序上并非如此:仅使用区室比例即可达到 0.469,而嵌入特征为 0.493(p = 0.77)。54 个可解释的细胞计数特征在每个程序上的差距仅为 0.043–0.085。
几何方法没有带来任何可测量的贡献,我们也解释了原因:测地线图通过欧氏最近邻搜索选择邻居,只对已选边进行重新加权,因此其拓扑在构建时就是欧氏的(黎曼几何减欧氏几何 = +0.0010,95% CI [-0.0007, +0.0029])。在一致应用时,几何方法表现更差(-0.0117)。岭回归优于图与度量解码器 +0.097(CI [+0.069, +0.127])。该领域常见的驱动基因计数指标在这里几乎没有信息量:91.8% 的随机六基因面板能够恢复 >=5/6 个驱动基因。

提交历史

来自:Chimdi Walter Ndubuisi [

查看电子邮件

]

[v1]

2026 年 7 月 31 日,周五,04:58:29 UTC(7,587 KB)

English / 原文

[Submitted on 31 Jul 2026]

Title:What Carries the Signal in Pathology Foundation-Model Atlases? A Patient-Level Controlled Benchmark in Breast Cancer

View a PDF of the paper titled What Carries the Signal in Pathology Foundation-Model Atlases? A Patient-Level Controlled Benchmark in Breast Cancer, by Chimdi Walter Ndubuisi

View PDF HTML (experimental)

Abstract:Pathology foundation models are reported to encode molecular programmes in tissue morphology, but the evidence is usually a cohort-wide ranked gene list rather than a prediction for a held-out patient. We rebuild such an analysis with the patient as the unit of evidence and ask which pipeline component carries signal.
Across 11 frozen backbones, four pre-specified gene programmes and 285 TCGA-BRCA patients with paired slides and RNA-seq (44 cells; GroupKFold by patient, all preprocessing fitted inside the fold), ridge regression on mean-pooled embeddings predicts held-out programme scores at Spearman rho = 0.25-0.56, UNI2 strongest on all four (immune 0.556). A matched permutation null gives raw p ~ 1e-4 at 10,000 permutations for every cell; Holm-adjusted p = 0.0044.
The signal is real but not uniformly morphological. Against competing models on the same patients and folds, embeddings beat tissue composition for ER/luminal, proliferation and immune (+0.280, +0.284, +0.479; p <= 0.003) but not basal, where compartment fractions alone reach 0.469 against the embedding's 0.493 (p = 0.77). Fifty-four interpretable cell-count features come within 0.043-0.085 on every programme.
The geometric machinery contributes nothing measurable, and we identify why: the geodesic graph selects neighbours by Euclidean nearest-neighbour search and only reweights edges already chosen, so the topology is Euclidean by construction (Riemannian minus Euclidean = +0.0010, 95% CI [-0.0007, +0.0029]). Applied consistently the geometry is worse (-0.0117). Ridge regression beats the graph-and-metric decoder by +0.097 (CI [+0.069, +0.127]). The driver-count metric common in this literature is near-uninformative here: 91.8% of random six-gene panels recover >=5/6 drivers.

Submission history

From: Chimdi Walter Ndubuisi [

view email

]

[v1]

Fri, 31 Jul 2026 04:58:29 UTC (7,587 KB)